Astragalin attenuates diabetic cataracts via inhibiting aldose reductase activity in rats.
Na WangDeepika SinghQiong Wu
Published in: International journal of ophthalmology (2023)
AST protects against lens opacification to avoid cataracts and polyols formation, indicating that it could be used as a potential therapeutic agent for diabetes.